Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Berkshire Hathaway. This analysis is provided for institutional research purposes only and is not investment advice.
"In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and a cautious stance on insurance markets while holding a fortress-like $370 billion in cash and Treasuries."
In his first annual letter to shareholders, Greg Abel honors the enduring legacy of Warren Buffett and Charlie Munger, reiterating Berkshire's commitment to its core values of decentralization, integrity, financial strength, and capital discipline. Berkshire delivered solid operating earnings of $44.5 billion in 2025, supported by an exceptional 87.1% combined ratio in insurance and a 34.5% operating margin at BNSF. Amidst increasing capital in reinsurance and rate reductions from competitors in primary lines, Berkshire expects to write less insurance premium in 2026. BHE continues to manage Western U.S. wildfire liabilities while preparing for a significant investment cycle driven by electricity demand for AI hyperscalers. Highlighting its disciplined acquisition approach, Berkshire announced the purchases of industrial chemicals provider OxyChem and rodent-control company Bell Laboratories. Berkshire's massive cash and Treasury holdings now exceed $370 billion, providing substantial dry powder for future compounding opportunities when prices fall below intrinsic value.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
Growth Outlook
Market outlook remains moderate conviction: In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
Risk Appetite
Risk appetite posture is low conviction: In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
Forward Guidance
Forward guidance signal: In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
Language Signal
Tone analysis indicates high conviction language: In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
Opportunity Density
Opportunity density index indicates moderate conviction actionable entry points. In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
Time Horizon
Investment time horizon reflects a high conviction orientation. In his inaugural shareholder letter, Greg Abel charts a steady course for Berkshire Hathaway, emphasizing capital discipline, the acquisition of OxyChem and Bell Laboratories, and ...
